CNE100005WX0
CNE100005WX0
CN BIO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 18.35B EUR | 17.72B EUR | 23.86B EUR | 22.61B EUR |
Enterprise Value | 18.73B EUR | 18.05B EUR | 24.42B EUR | 23.07B EUR |
Valuation Multiples | ||||
Trailing P/E | 31.62x | 40.73x | 54.86x | 36.92x |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 4.2x | 5.41x | 7.17x | 6.41x |
Price to Book | 2.3x | 2.22x | 2.91x | 2.8x |
EV/Revenue | 4.29x | 5.51x | 7.34x | 6.54x |
EV/EBITDA | 14.14x | 32.7x | 42.02x | 28.99x |
Price to FCF (P/FCF) | 22.57x | 25.71x | 64.42x | 72.67x |
EV/FCF | 23.04x | 26.19x | 65.92x | 74.13x |
FCF Yield | 4.43% | 3.89% | 1.55% | 1.38% |